Related Experiment Videos
[Melanoma simulating malignant soft tissue tumour]
1Ustav patologické anatomie FN a LF MU, Brno.
Ceskoslovenska Patologie
|December 31, 2005
Summary
This study tracks melanoma progression, showing how tumor cells change in appearance and immune markers with each metastasis. The evolving phenotype complicates diagnosis, mimicking other cancers like malignant fibrous histiocytoma.
Area of Science:
- Oncology
- Dermatopathology
- Cancer Biology
Background:
- Primary nodular melanoma can exhibit complex metastatic behavior.
- Understanding tumor progression is crucial for accurate diagnosis and treatment.
- Immunophenotypic changes during metastasis are not fully understood.
Observation:
- An 82-year-old man with primary nodular melanoma experienced five cervical lymph node metastases.
- Initial tumor cells were round/oval melanoblasts, positive for S100, HMB45, Melan A, and MITF.
- Subsequent metastases showed morphological changes to spindle cells and multinucleated cells, resembling malignant fibrous histiocytoma.
Findings:
- Tumor immunophenotype shifted during progression; later metastases were only S100 protein positive.
- Loss of HMB45, Melan A, and MITF expression occurred in advanced metastatic disease.
- Histological patterns evolved, mimicking mesenchymal tumors, complicating differential diagnosis.
Implications:
- Phenotypic and immunophenotypic plasticity in melanoma metastasis presents diagnostic challenges.
- Differential diagnosis must include mesenchymal tumors like malignant fibrous histiocytoma.
- Further research into melanoma evolution can improve diagnostic accuracy and therapeutic strategies.